期刊文献+

临床药师参与1例心衰伴高钾血症患者的药学实践

Pharmaceutical care for a heart failure patient with hyperkalemia
下载PDF
导出
摘要 目的通过临床药师实践过程,探索临床药师的工作方式及思维方法。方法参与1例心衰伴高钾血症的治疗,充分利用专业背景,在高钾血症查因、药物不良反应的监测等环节,作为临床治疗团队一员,为患者提供全面的药学服务。结果临床药师参与的临床治疗团队能更好地为患者提供服务,该心衰患者在优化治疗方案后能避免血钾升高。结论临床药师参与临床治疗,有利于发挥药师在治疗团队中的作用,促进临床合理用药,保障患者用药安全。 Objective To explore the working and thinking mode of clinical pharmacists in clinical practice. Methods Clinical pharmacists joined the treatment team and provided pharmaceutical care for a heart failure patient with hyperkalemia, such as checking the hyperkalemia, and monitoring the adverse drug reaction (ADR). Results The treatment team provided better care with the help of clinical pharmacists. The heart failure patient avoided potassium rise after optimization of the treatment. Conclusion Involvement of clinical pharmacists in therapeutic practice improves the security and efficacy of pharmacotherapy.
作者 刘贺萍 李晋 季波 LIU He-ping LI Jin JI Bo(Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou Key Laboratory of Rational Drug Use for the Elderly with Chronic Diseases, Guangzhou 510O10)
出处 《中南药学》 CAS 2017年第9期1335-1337,共3页 Central South Pharmacy
基金 广州市科技计划项目(No.201509010012)
关键词 临床药师 心衰 高钾血症 clinical pharmacist heart failure hyperkalemia
  • 相关文献

参考文献1

二级参考文献11

  • 1迟丹怡,王大猷.口服地高辛药学监护的几点认识[J].中南药学,2003,1(2):115-116. 被引量:3
  • 2Chekman IS.Pharmacotherapy of patients with chronic heart failure.Analysis of multicen-ter international studies[J].Lik Sprava,2008,11(2):60.
  • 3Tuncok Y,Hazan E,Oto O,et al.Relationship between highserum digoxin levels and toxicity[J].Int J Clin Pharmacol Ther,1997,35(9):366-368.
  • 4国家药典委员会.《中华人民共和国药典·临床用药须知》[S].2010:205.
  • 5Kirimli O,Kalkan S,Guneri S,et al.The effects of captopril on serum digoxin levels in patients with severe congestive heart failure[J].Int J Clin Pharmacol Ther,2001,39(7):311-314.
  • 6Bachmakov I,Werner U,Endress B,et al.Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein[J].Fundam Clin Pharmacol,2006,20(3):273.
  • 7Boyd RA,Stern RH,Stewart BH,et al.Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion[J].J Clin Pharmacol,2000,40(1):91-98.
  • 8Sakaeda T,Fujino H,Komoto C,et al.Effects of acid andlactone forms of eight HMG-Co A reductase inhibitors on CYP mediated metabolism and MDR1-mediated transport[J].Pharm Res,2006,23:506-512.
  • 9赵文丽,张世俊.地高辛与常用药物的相互作用及用药策略[J].中国医院用药评价与分析,2012,12(5):477-480. 被引量:27
  • 10李倩,王雪明,西娜.我院101例地高辛中毒临床相关因素分析[J].中国药房,2015,26(2):209-212. 被引量:20

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部